Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management

Malignant melanoma accounts for about 1% of all skin cancers, but it causes most of the skin cancer-related deaths. Circulating tumor DNA (ctDNA) testing is emerging as a relevant tool for the diagnosis and monitoring of cancer. The availability of highly sensitive techniques, including next generat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerando Botti, Nicola Normanno
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2020-10-01
Serija:Cancers
Teme:
ctDNA
melanoma
liquid biopsy
prognosis
prediction
patient stratification
Online pristup:https://www.mdpi.com/2072-6694/12/10/2914
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items